Alterity Therapeutics Limited (PRNAF) has a market capitalization of $11.96M and trades at $0.00. The 52-week range is 0.0002-0.0139.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $0.00, annual revenue of $5.44M.
The stock has a beta of -0.07, operates in the Healthcare sector.